VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2019 | Future treatment options for squamous cell lung cancer

Paul Paik • 3 Jun 2019
ASCO 2019
Lung Cancer

Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.

More from Paul Paik

1:04
Tepotinib: advanced non-small cell lung cancer
Paul Paik
0:48
Patient impact: development of drugs to treat METex14 alterations
Paul Paik • 3 Jun 2019
0:55
Squamous cell lung cancer: gene targets
Paul Paik • 3 Jun 2019

Related Videos

1:40
IASC WCLC 2021: CX-2029 and AMG 757 for lung cancer
Melissa Johnson • 8 Jan 2021
2:38
Key lung cancer updates: KRAS(G12C) inhibitors and ADCs
Melissa Johnson • 8 Jan 2021
2:57
NGS key for optimal lung cancer treatment
Melissa Johnson • 8 Jan 2021
1:29
Updates from the Sarah Cannon Research Institute
Melissa Johnson • 8 Jan 2021
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals